Document Detail

Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature.
MedLine Citation:
PMID:  20815695     Owner:  NLM     Status:  MEDLINE    
Prophylactic fresh-frozen plasma (FFP) transfusion is often undertaken in hemodynamically stable patients with a minimally elevated international normalized ratio (INR) prior to invasive procedures, despite little evidence in support of this practice. The authors review the current literature in an attempt to clarify best clinical practice with regard to this issue. Although the activated partial thromboplastin time and prothrombin time-INR are useful laboratory tests to measure specific clotting factors in the coagulation cascade, in the absence of active bleeding or a preexisting coagulopathy, their utility as predictors of overall bleeding risk is limited. Several studies have shown an imperfect correlation between mild elevations in the INR and subsequent bleeding tendency. Furthermore, FFP transfusion is not always sufficient to achieve normal INR values in patients who have mild elevations (< 2) to begin with. Finally, there are risks associated with FFP transfusion, including potential transfusion-associated [disease] exposures as well as the time delay imposed by laboratory testing and transfusion administration prior to initiation of procedures. The authors propose that the current concept of a "normal" INR value warrants redefinition to make it a more meaningful clinical tool. Based on their review of the literature, the authors suggest that in a hemodynamically stable patient population there is a range of mildly prolonged INR values for which FFP transfusion is not beneficial, and is potentially harmful.
Kelly L West; Cory Adamson; Maureane Hoffman
Related Documents :
9876295 - Renal dysfunction in patients with sickle cell anemia or sickle cell trait.
9371095 - Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic re...
2672235 - Autotransfusion and blood conservation in urologic oncology.
10849385 - Alloimmunization in chinese with warm autoimmune haemolytic anaemia - incidence and cha...
16715325 - Amplitude-integrated eeg (aeeg) predicts outcome after cardiac arrest and induced hypot...
22794695 - Chapter 22: hereditary and acquired angioedema.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review     Date:  2010-09-03
Journal Detail:
Title:  Journal of neurosurgery     Volume:  114     ISSN:  1933-0693     ISO Abbreviation:  J. Neurosurg.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-03     Completed Date:  2011-02-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0253357     Medline TA:  J Neurosurg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  9-18     Citation Subset:  AIM; IM    
Department of Pathology, Duke University, Durham, North Carolina, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Transfusion / utilization*
Factor VIIa / therapeutic use
Hemostasis, Surgical
International Normalized Ratio*
Neurosurgical Procedures / methods*
Partial Thromboplastin Time
Prothrombin Time
Recombinant Proteins / therapeutic use
Reg. No./Substance:
0/Recombinant Proteins; 0/recombinant FVIIa; EC VIIa
Comment In:
J Neurosurg. 2011 Jan;114(1):8; discussion 8   [PMID:  20815696 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.
Next Document:  International normalized ratio.